VARIABLE | FREQUENCY (%) |
Initial clinical presentation |
|
Asymptomatic | 34 (16.75) |
Lower urinary tract symptoms | 125 (61.58) |
Acute urinary retention | 44 (21.67) |
Complications |
|
None | 196 (96.55) |
Paraplegia | 4 (1.97) |
Hip fractures | 1 (0.49) |
Lymphoedema | 2 (0.99) |
DRE findings |
|
Remarkable | 88 (43.35) |
Unremarkable | 115 (56.65) |
BMI ranges |
|
<18.5 | 1 (0.49) |
18.5 - 24.9 | 61 (30.20) |
25 - 29.9 | 96 (47.52) |
30 - 34.9 | 39 (19.21) |
35 - 39.9 | 5 (2.46) |
≥40 | 1 (0.49) |
Serum PSA levels (ng/ml) |
|
4 - 40 | 96 (47.29) |
40.1 - 80 | 34 (16.75) |
80.1 - 120 | 9 (4.43) |
120.1 - 160 | 12 (5.91) |
160.1 - 200 | 10 (4.93) |
>200 | 42 (20.69) |
Anemia |
|
Yes | 100 (49.26) |
No | 103 (50.74) |
Aggressive cancer |
|
Yes | 36 (17.73) |
No | 167 (82.27) |
Prostate volume (ml) |
|
≤20 | 5 (2.46) |
20.1 - 40 | 41 (20.20) |
40.1 - 60 | 61 (30.05) |
60.1 - 80 | 46 (22.66) |
80.1 - 100 | 23 (11.33) |
>100 | 27 (13.30) |
Abnormal echostructure |
|
Yes | 59 (29.06) |
No | 144 (70.94) |